These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures. Grabowski H Pharmacoeconomics; 2004; 22(2 Suppl 2):15-24. PubMed ID: 15660474 [TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical research: cost savings through innovation. Cohen KR; Levy RA AAPPO J; 1993 Oct; 3(5):28-36. PubMed ID: 10146463 [No Abstract] [Full Text] [Related]
11. The role of the private sector in biotechnology: research and development. Feisee L Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359 [No Abstract] [Full Text] [Related]
12. Prescription for an ailing pharmaceutical industry. Demain AL Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826 [No Abstract] [Full Text] [Related]
13. The importance of patent term restoration to small, high technology companies. Kiley TD Health Aff (Millwood); 1982; 1(2):46-52. PubMed ID: 7185722 [No Abstract] [Full Text] [Related]
14. Measure for measure. Dughan L Biotechnology (N Y); 1995 Sep; 13(9):949-53. PubMed ID: 9678952 [No Abstract] [Full Text] [Related]
15. Biotechnology's metamorphosis into a drug discovery industry. Drews J Nat Biotechnol; 1998 May; 16 Suppl():22-4. PubMed ID: 9591258 [No Abstract] [Full Text] [Related]
17. Eli Lilly enters venture capital arena. Fletcher L Nat Biotechnol; 2001 Nov; 19(11):997-8. PubMed ID: 11689830 [No Abstract] [Full Text] [Related]
18. Patent term extension: an expensive and unnecessary giveaway. Gore A Health Aff (Millwood); 1982; 1(2):25-33. PubMed ID: 10621692 [No Abstract] [Full Text] [Related]